The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease

Paul A. Gurbel, Thomas O. Bergmeijer, Udaya S. Tantry, Jurrien M. ten Berg, Dominick J. Angiolillo, Stefan James, Tomas L. Lindahl, Peter Svensson, Joseph A. Jakubowski, Patricia B. Brown, Suman Duvvuru, Scott Sundseth, Joseph R. Walker, David Small, Brian A. Moser, Kenneth J. Winters, David Erlinge

Research output: Contribution to journalArticlepeer-review

24 Citations (SciVal)

Fingerprint

Dive into the research topics of 'The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease'. Together they form a unique fingerprint.

Medicine & Life Sciences